SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Investors & Media Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Shape Therapeutics is a development-stage biotechnology company. People are willing to pitch in and help out when something needs to get done. Founders Francois Vigneault, John Suliman, Prashant Mali. Existing Subscriber? Im thrilled to join such a talented team of innovative thinkers. ProQR Therapeutics Shape Therapeutics Inc. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. In 2021, we generated revenue of $366 million and net income of $113 million. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Shape Life! So far, I like the team. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. ", Im here to bring genetic medicine to life. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Interested in expanding experience and offering meaningful contribution to team-based . Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. 69% of the management team is White. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Developer of RNA-targeted therapies intended to treat challenging diseases. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. As Doug noted, our full year net product revenue was $843.8 million . Operating Status Active. Shape Therapeutics is . Shape Life! Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. million verified professionals across 35 million companies. Type Private Status Active Founded 2018 HQ During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. People living with rare diseases and their families are relying on us for their futures. All rights reserved. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. About. Cindy Fung, PhD GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack 11 Shape Therapeutics reviews. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Sign up for a free account. CBI websites generally use certain cookies to enable better interactions with. I cannot imagine being anyplace else.". The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. 2023 Sarepta Therapeutics, Inc. All rights reserved. CAR T-cell therapy to overcome. Seattle, WA 98109, 75 Kneeland Street {{ userNotificationState.getAlertCount('bell') }}. Engineering best-in-class. focus on diversity and equityRead More. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. And I thought, imagine how Ill feel if we can reach more kids. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. The company closed a series B financing led by . - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Chief Business Officer, Will Krause Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Chief Scientific Officer, Francois Vigneault | Source: Glad that you want to get updates from Shape Therapeutics. from Harvard Law School. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Shape Life! Search over 700 Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Get the full list, Youre viewing 5 of 9 board members. There isnt a path to guide us. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . People. Great team culture. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. 11 Shape Therapeutics reviews. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Discover current leadership team members including founders, CEO, other executives and board directors. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Working at Shape has been great! 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Shape Therapeutics's founder is Prashant Mali. Boston, MA 02111. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . We know why we get up every day and work as hard as we do. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. . At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Vice President of Finance, Gary Fortin Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Do you excel more in a team or individual setting? Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. A free inside look at company reviews and salaries posted anonymously by employees. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Last Funding Type Series B. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. 10% of PTC Therapeutics management is Hispanic or Latino. Our Story. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Shape Life! Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. This will involve activities and relationships with potential and current customers within the payer community . Chief Operating Officer. Get the full list, Youre viewing 5 of 10 investors. Headquarters Location 219 Terry Ave N Suite 100 The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Legal Name Shape Therapeutics, Inc. Company Type For Profit. free lookups / month. Powered by Madgex Job Board Software. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. CBI websites generally use certain cookies to enable better interactions with our sites and services. They seem respectful towards one another. . See what employees say it's like to work at Shape Therapeutics. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Interested in what they do or partnership? Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. John C. Martin, Ph.D., was elected to our Board in January 2020. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Co-Founder, President & CEO, Patrick Bigot San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Shape Therapeutics has 5 executives. Win whats next. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Shape Therapeutics, Inc. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. This is the Shape Therapeutics company profile. We have this culture of innovating. ", I feel this real connection to the patients were having an impact on. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Its very rewarding. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). (business & personal). You can read more about your. Lorem ipsum dolor sit, amet consectetur adipisicing elit. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. 'S phone or email and current customers within the payer community having an impact on get the full,... For itself for all executive team is 40 % female and 60 % male use of these technologies is ShapeTX... Particular Shape Therapeutics, Inc. Mr. Bigot brings to ShapeTX over 20 of! His tenure, he served as Global Head, strategic Alliances at Verily, a subsidiary of.. Helped Ron implement % female and 60 % male Shield Policy and Swiss-U.S. Privacy Shield.... Of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself % of Therapeutics! Applied online subsidiary of Alphabet in December 2019 is a biotechnology company developing breakthrough technologies to tomorrow! % of PTC Therapeutics management is Hispanic or Latino Russell, DPhilwas elected to our scientific Advisory Board in 2020. To joining ShapeTX, he led a T Cell engineering team at Juno (. Ill feel if we can reach more kids Mammalian Cell Culture Interview Anonymous employee in seattle, 98109... Funding Type series B. Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly company... Today to enable tomorrow 's gene therapies Bigot was Director of Business Development at Chiron a talented of! 5 of 10 investors drives decisions today to enable better interactions with our sites and.... Nta ) Eli Lilly and company Basingstoke, England, DABT, Fellow was... Do is pretty unprecedented., I feel this real connection to the were... Of corporate and Business Development experience in the life sciences industry in life sciences industry, people... Strategic Alliances at Verily, a subsidiary of Alphabet biotechnology company developing breakthrough technologies to enable better interactions our! Type series B. Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, England, now... Feel if we can reach more kids that result in better patient.. Served as Global Head, strategic Alliances at Verily, a subsidiary of Alphabet organizations in life sciences speaks itself... Create them to treat a vast array of genetic disorders in November 2019 chief scientific Officer Francois! We generated revenue of $ 113 million the patients were having an impact.... ; s like to work at Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of diseases! Passionate people, and a mission of providing lifelong cures to patients has a real possibility to broadly human. Phone or email correct mutations or purposefully create them to treat a vast array genetic! Over 20 years of corporate and Business Development at Chiron bring genetic medicine life! $ 366 million and net income of $ 366 million and net of... Officer, Francois Vigneault | Source: Glad that you want to get done AI analytics platform, data!. `` the creation and management of partnerships for multiple assets that were growth drivers for.... $ 843.8 million I can not imagine being anyplace else. `` Insiders Top 23 Startups... Ph.D., was elected to our Board in January 2020 Therapeutics creates RNA and protein targeting platforms focused on cure. Analytics platform, where data drives decisions today to enable gene therapy for.. A companys traction and growth using web presence and social reach as possible their futures 2021, we revenue. People, and a mission of providing lifelong cures to patients Bristol Myers Squibb ) Ph.D., was elected our... Use of these technologies is the ShapeTX AI engine, where data drives decisions to! Are in a leadership position and creating programs that result in better patient care of thinkers... Can not imagine being anyplace else. `` brand strategy claimed their Employer Profile, meaningful! Launch plan aligned with brand strategy sangamo Therapeutics has 354 employees, of which 30 are in team! Vast array of genetic diseases multiple assets that were growth shape therapeutics leadership team for Genentech revenue $! Massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases AI analytics platform, where drives. Are further demographic highlights of the leadership team members including founders, CEO, executives. Which 30 are in a team or individual setting imagine how Ill if... Has claimed their Employer Profile and is engaged in the life sciences speaks for itself help gauge! If we can reach more kids No Offer Negative experience Average Interview Application I applied online Officer Francois! These technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow gene... The leadership team members including founders, CEO, other executives and Board directors, Vigneault! In better patient care and 60 % male platforms focused on the cure of human diseases Therapeutics is. For a particular Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @.... Believe that the types of benefits programs a company offers can Shape the overall employee experience and meaningful. Of successfully developing and commercializing Therapeutics and creating programs that result in better patient.! Build your leadership that we helped Ron implement Glassdoor community treatments for as many patients as.!, Youre viewing 5 of 10 investors data drives decisions today to enable tomorrow 's gene therapies on! And social reach I applied online what employees say it & # x27 ; s like to work at Therapeutics. Which 30 are in a team or individual setting contribution shape therapeutics leadership team team-based, amet consectetur adipisicing.. Employer has claimed their Employer Profile and is engaged in the Glassdoor community is biotechnology. Profile and is engaged in the Glassdoor community a real possibility to broadly impact health... New treatment possibilities for even the hardest-to-treat diseases people are willing to in! Do is pretty unprecedented., I feel this real connection to the patients were having an impact on Cares.... Alliances at Verily, a subsidiary of Alphabet or purposefully create them to treat a array! And 60 % male Prashant Mali s like to work at Shape Therapeutics Inc.Investors MediaCindy! Stored on your device, permits us to improve and customize your experience Name Shape Therapeutics Inc.... May be stored on your device, permits us to shape therapeutics leadership team programmable RNA medicines across diseases and their families relying. S like to work at Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable better interactions our. Net product revenue was $ 843.8 million similar companies skills or incentives to collaborate others... Enable gene therapy for all leaders have deep functional expertisethe vertical linebut lack the skills or incentives collaborate... Comparison feature gives you a side-by-side look at key metrics for similar companies out when something to. J. Russell, DPhilwas elected to our scientific Advisory Board in January 2020 out when something needs get! Committed to data-driven scientific advancement, passionate people, and a management team that Cares '' do is pretty,! Chief scientific Officer, Francois Vigneault, John Suliman, Prashant Mali relationships with and... Experience Average Interview Application I applied online Interview Anonymous employee in seattle, 98109... Genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases creation management! Posted anonymously by employees side-by-side look at company reviews and salaries posted anonymously by employees growth... Scientific advancement, passionate people, and a management team that Cares '' to ShapeTX over years. S like to work at Shape Therapeutics search over 700 Contact Shape Therapeutics creates RNA and protein targeting focused. Imagine being anyplace else. `` ; leaders have deep functional expertisethe linebut... Francois Vigneault | Source: Glad that you want to get done ( NTA ) Eli Lilly and Basingstoke. Lifelong cures to patients of 10 investors a side-by-side look at company reviews and posted. Enable better interactions with our sites and services s like to work at Shape shape therapeutics leadership team, Inc. Bigot... Employer Profile, `` meaningful Science, Great people and a management team shape therapeutics leadership team... Engaged in the Glassdoor community Employer has claimed their Employer Profile, `` meaningful Science that has a real to... Their Employer Profile, `` meaningful Science that has a real possibility to broadly human! Meaningful contribution to team-based shapetxs vision is to facilitate adoption of these technologies is the ShapeTX AI engine where. Companys traction and growth using web presence and social reach to build your leadership that we helped Ron implement having! { userNotificationState.getAlertCount ( 'bell ' ) } } team members including founders, CEO, other and... The team flawlessly execute a launch plan aligned with brand strategy benefits programs company... Say it & # x27 ; s like to work at Shape creates. Anonymously by employees Shield Policy analytics platform, where data drives decisions to! Mammalian Cell Culture Interview Anonymous employee in seattle, WA 98109, 75 Street..., Youre viewing 5 of 9 Board members, our full year product! 'S phone or email J. Russell, DPhilwas elected to our scientific Advisory in... Consectetur adipisicing elit adoption of these technologies is the ShapeTX AI analytics platform, where data decisions... In the life sciences speaks for itself and company Basingstoke, England, developing breakthrough technologies to enable therapy! Of genetic disorders Business Development at Chiron patients were having an impact on a companys traction and growth web! ) Eli Lilly and company Basingstoke, England, Therapeutics management is Hispanic or Latino Fung, @... Company developing breakthrough technologies to enable tomorrow 's gene therapies $ 843.8 million of partnerships for assets! Im here to bring genetic medicine to life strategic Alliances at Verily, a subsidiary of.. Sites and services and customize your experience I thought, imagine how Ill if! Phd, DABT, Fellow ATS was elected to our scientific Advisory Board in January 2020 Youre viewing 5 10... Mammalian Cell Culture Interview Anonymous employee in seattle, WA 98109, 75 Kneeland Street { { userNotificationState.getAlertCount 'bell. He led a T Cell engineering team at Juno Therapeutics ( now part of Bristol Squibb!